Walleye Trading’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10M Buy
234,744
+15,359
+7% +$834K 0.01% 947
2026
Q1
$13.8M Buy
219,385
+23,928
+12% +$1.91M 0.02% 650
2025
Q4
$18.6M Buy
195,457
+126,696
+184% +$12.4M 0.03% 648
2025
Q3
$6.71M Sell
68,761
-60,675
-47% -$6.28M 0.01% 1095
2025
Q2
$13.9M Buy
129,436
+23,268
+22% +$2.35M 0.03% 681
2025
Q1
$10.7M Sell
106,168
-72,245
-40% -$7.27M 0.02% 685
2024
Q4
$15.9M Buy
178,413
+36,235
+25% +$3.19M 0.03% 567
2024
Q3
$11.9M Buy
142,178
+8,881
+7% +$700K 0.03% 688
2024
Q2
$10.3M Buy
133,297
+61,436
+85% +$4.5M 0.02% 660
2024
Q1
$4.92M Buy
71,861
+36,825
+105% +$2.37M 0.01% 1130
2023
Q4
$2.03M Buy
35,036
+25,601
+271% +$1.37M ﹤0.01% 1919
2023
Q3
$498K Buy
+9,435
New +$495K ﹤0.01% 2966
2022
Q3
Sell
-32,582
Closed -$1.31M 5066
2022
Q2
$1.21M Sell
32,582
-10,347
-24% -$421K ﹤0.01% 2052
2022
Q1
$1.9M Sell
42,929
-64,943
-60% -$2.81M 0.01% 1704
2021
Q4
$4.58M Sell
107,872
-56,615
-34% -$2.38M 0.02% 1045
2021
Q3
$7.14M Buy
164,487
+83,436
+103% +$3.69M 0.03% 729
2021
Q2
$3.47M Buy
81,051
+31,847
+65% +$1.34M 0.01% 1046
2021
Q1
$1.9M Sell
49,204
-33,433
-40% -$1.27M 0.01% 1371
2020
Q4
$2.97M Buy
+82,637
New +$2.98M 0.01% 1092
2020
Q3
Sell
-85,520
Closed -$3.3M 4133
2020
Q2
$3M Buy
85,520
+60,537
+242% +$2.18M 0.02% 818
2020
Q1
$815K Sell
24,983
-72,726
-74% -$2.84M 0.01% 1457
2019
Q4
$4.42M Buy
97,709
+62,707
+179% +$2.62M 0.03% 644
2019
Q3
$1.42M Sell
35,002
-42,976
-55% -$1.82M 0.01% 1337
2019
Q2
$3.35M Buy
77,978
+16,724
+27% +$643K 0.03% 694
2019
Q1
$2.35M Buy
61,254
+24,841
+68% +$949K 0.02% 946
2018
Q4
$1.29M Buy
36,413
+20,596
+130% +$747K 0.01% 1458
2018
Q3
$609K Sell
15,817
-70,803
-82% -$2.47M ﹤0.01% 2663
2018
Q2
$2.83M Buy
86,620
+45,493
+111% +$1.37M 0.02% 1015
2018
Q1
$1.12M Buy
41,127
+19,842
+93% +$539K 0.01% 1805
2017
Q4
$528 Sell
21,285
-1,580
-7% -$43.6K ﹤0.01% 2551
2017
Q3
$667 Buy
22,865
+4,408
+24% +$122K ﹤0.01% 2216
2017
Q2
$512 Sell
18,457
-17,486
-49% -$464K ﹤0.01% 2352
2017
Q1
$894 Sell
35,943
-12,907
-26% -$314K 0.01% 1742
2016
Q4
$1.06M Sell
48,850
-32,269
-40% -$704K 0.01% 1471
2016
Q3
$1.93M Buy
81,119
+56,770
+233% +$1.35M 0.01% 996
2016
Q2
$569K Buy
+24,349
New +$527K ﹤0.01% 2094
2016
Q1
Sell
-19,733
Closed -$347K 5329
2015
Q4
$364K Buy
+19,733
New +$354K ﹤0.01% 2142
2015
Q2
Sell
-139,736
Closed -$2.5M 4825
2015
Q1
$2.48M Buy
139,736
+109,134
+357% +$1.72M 0.02% 546
2014
Q4
$405K Buy
30,602
+24,466
+399% +$313K ﹤0.01% 1737
2014
Q3
$72K Buy
+6,136
New +$77.3K ﹤0.01% 2884
2014
Q2
Sell
-13,678
Closed -$178K 3704
2014
Q1
$185 Sell
13,678
-86,602
-86% -$1.14M ﹤0.01% 1966
2013
Q4
$1.21M Buy
100,280
+80,920
+418% +$956K 0.01% 966
2013
Q3
$227K Buy
+19,360
New +$209K ﹤0.01% 1639

Other funds holding BSX

Walleye Trading's BSX Position: Q2 2026 in Review

Walleye Trading increased its Boston Scientific (BSX) stake by 7% in Q2 2026, buying an estimated $834K and bringing the position to 234,744 shares worth $10M. The position accounts for 0.01% of the portfolio, ranked #947.

Walleye Trading first reported a position in BSX in Q3 2013 and has held it in 43 quarters since. The position peaked at $18.6M in Q4 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Walleye Trading held 234,744 shares of Boston Scientific worth $10M as of Q2 2026.
  • Walleye Trading bought 15,359 Boston Scientific shares in Q2 2026, an estimated $834K.
  • Boston Scientific made up 0.01% of Walleye Trading's portfolio in Q2 2026, its #947 holding.
  • Walleye Trading first reported a position in Boston Scientific in Q3 2013 and has held it in 43 quarters since.
  • Walleye Trading's Boston Scientific position peaked at $18.6M in Q4 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.